Takeda
TAK
Performance
About Takeda
Takeda is a global biopharmaceutical company focused on discovering and developing medicines across multiple areas including oncology, immunology, hematology, vaccines, and rare diseases. With R&D-driven science and a patient-centric approach, the company aims to bring Better Health and a Brighter Future to people worldwide, with operations spanning its headquarters in Japan and presence across global markets.
Recent News
Dizal Breaks New Ground for EGFR Drugs in Lung Cancer
Takeda Breaks Up With Denali, Dumps Dementia Drug
Daito Pharmaceutical Posts 86% Nine‑Month Profit Surge on New Drug Sales
Pharma and Biotech Layoffs 2026 Watch
Spyre Therapeutics Jumps 25% on Positive Phase 2 SKYLINE Data
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Senju Launches First-in-Class Dry Eye Disease Drug in Japan
JPM26: Filling C-Suites, Union Square—And Elevators—With Pink
More Pharma Dealmaking; FDA’s Proposed Budget; Takeda Ends Partnership; and More
Proteasomes: A Novel Approach to Target the Immune System
CMS's Medicare Price Negotiations Start Round Three
Mezagitamab Shows Promise in Treating Immune Thrombocytopenia Patients
Biopharmas Pull Back on Layoffs in Q1
EU Approves Otsuka's Long-Acting HAE Drug Dawnzera
The FDA Has Released Draft Guidance for NAMs Validation – Now What?
11 Companies Hiring Manufacturing Professionals Now
Hiring Outlook: February Brings First YOY Job Increase Since 2022
More Changes Ahead for Takeda with New CEO Set to Take Reins
Wave To Work Alone on RNA Editor as AATD Picture Becomes Clearer
PDA Week 2026 Showcased AI, Knowledge Management, and Proactive Quality Culture
UK Names Health Data Chief, as BIA Finds Its New CEO
Alumis Soars as TYK2 Drug Hits Mark in Psoriasis Trials
Denali Regains Full Rights to Frontotemporal Dementia Therapy as Takeda Exits DNL593 Pact
Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights
Pig Liver Xenotransplant Shows Promise, but More Work Remains
Pharma Pipeline Stalls for First Time in Decades: Citeline
Is Algae The Answer To Carbon Capture? Intrinsic Foundries’ Green Fix For Toxic Waste
FDA Kicks Off Review of Takeda's Narcolepsy Hopeful
Halozyme Diversifies in Drug Delivery with Surf Bio Buy
Takeda, Iambic Sign Multiyear R&D Deal for AI Drug Discovery
Abivax in No Rush for a Deal, Confident Key June Trial Data Can Secure Better Terms for Partnerships, CEO Tells CNBC
BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
The Next Cambridge? LA Sets Its Sights Higher
JPM26: KalVista’s HAE Win Is a ‘Tale of Two Markets’
‘Over and Above’ Responses Seen with Envudeucitinib for Plaque Psoriasis
Zelestra Brings Spanish 162MW Solar PV Portfolio Online
Axsome Therapeutics Acquires Global Rights to Balipodect From Takeda
The Top 12 Companies Hiring in Biopharma Now
Recent Deals
No recent deals for this company.
